Sentinel lymph node evaluation for tumor metastasis

Seminars in Diagnostic Pathology

Volumn 19, Issue 4, 2002, Pages 263-277

  Hunt, Jennifer L ^a   Baloch, Zubair W ^a   LiVolsi, Virginia A ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Histology; Immunohistochemistry; Micrometastasis; Sentinel lymph node; Tissue processing

Indexed keywords

BREAST CARCINOMA; CLINICAL PROTOCOL; CONSULTATION; HISTOPATHOLOGY; HUMAN; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; MELANOMA; METASTASIS; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE; STANDARDIZATION; IMMUNOHISTOCHEMISTRY; LABORATORY DIAGNOSIS; LYMPH NODE METASTASIS; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; SENTINEL LYMPH NODE BIOPSY;

HUMANS; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; PATHOLOGY, SURGICAL; SENTINEL LYMPH NODE BIOPSY; SPECIMEN HANDLING;

EID: 0036853630     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (137)

1. Dees EC, Shulman LN, Souba WW, et al: Does information from axillary dissection change treatment in clinically node-negative patients with breast cancer? An algorithm for assessment of impact of axillary dissection. Ann Surg 226:279-286, 1997
2. Schwartzberg LS, Birch R, Tauer KW, et al: Adjuvant dose-intense chemotherapy with peripheral blood stem cell support in stage II-III breast cancer with five to nine involved axillary lymph nodes. Am J Clin Oncol 22:136-142, 1999
3. Petrek JA, Senie RT, Peters M, et al: Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92:1368-1377, 2001
4. Karlsson P, Holmberg E, Samuelsson A, et al: Soft tissue sarcoma after treatment for breast cancer - A Swedish population-based study. Eur J Cancer 34:2068-2075, 1998
5. Rampaul R, Miremadi A, Pinder S, et al: Pathological validation and significance of micrometastasis in sentinel nodes in primary breast cancer. Breast Cancer Res 3:113-116, 2001
6. Haddadin KJ, Soutar DS, Oliver RJ, et al: Improved survival for patients with clinically T1/T2. N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 21:517-525, 1999
7. Buckley JG, Feber T: Surgical treatment of cervical node metastases from squamous carcinoma of the upper aerodigestive tract: Evaluation of the evidence for modifications of neck dissection. Head Neck 23:907-915, 2001
8. Pillsbury HC, Clark M: A rationale for therapy of the N0 neck. Laryngoscope 107:1294-1315, 1997
9. Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 39:456-466, 1977
10. Perinetti E, Crane DB, Catalona WJ: Unreliability of sentinel lymph node biopsy for staging penile carcinoma. J Urol 124:734-735, 1980
11. Wespes E, Simon J, Schulman CC: Cabanas approach: Is sentinel node biopsy reliable for staging penile carcinoma? Urology 28:278-279, 1986
12. Pettaway CA, Pisters LL, Dinney CP, et al: Sentinel lymph node dissection for penile carcinoma: The M. D. Anderson Cancer Center experience. J Urol 154:1999-2003, 1995
13. Morton DL, Wen DR, Wong JH, et al: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127:392-399, 1992
14. Giuliano A, Kirgan D, Guenther J, et al: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220:391-398, 1994
15. Alex JC, Weaver DL, Fairbank JT, et al: Gamma-probe-guided lymph node localization in malignant melanoma. Surg Oncol 2:303-308, 1993
16. Krag DN, Weaver DL, Alex JC, et al: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2:335-339, 1993
17. Albertini JJ, Lyman GH, Cox C, et al: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. Jama 276:1818-1822, 1996
18. Pijpers R, Borgstein PJ, Meijer S, et al: Sentinel node biopsy in melanoma patients: Dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 21:788-792, 1997
19. McMasters KM, Reintgen DS, Ross MI, et al: Sentinel lymph node biopsy for melanoma: How many radioactive nodes should be removed? Ann Surg Oncol 8:192-197, 2001
20. Velanovich VSzymanski W: Quality of life of breast cancer patients with lymphedema. Am J Surg 177:184-187, 1999
21. Giuliano AE, Haigh PI, Brennan MB, et al: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. Journal of Clinical Oncology 18:2553-2559, 2000
22. Schrenk P, Rieger R, Shamiyeh A, et al: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88:608-614, 2000
23. Tafra L, McMasters KM, Whitworth P, et al: Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 180:268-273, 2000
24. Gadd M, Cosimi A, Yu J, et al: Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg 134:381-387, 1999
25. Gershenwald J, Colome M, Lee J, et al: Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 16:2253-2260, 1998
26. Yared MA, Middleton LP, Smith TL, et al: Recommendations for sentinel lymph node processing in breast cancer. Am J Surg Pathol 26:377-382, 2002
27. silverberg sg: sentinel node processing: recommendations for pathologists. Am J Surg Pathol 26:383-385, 2002
28. Anderson T: The challenge of sentinel lymph node biopsy. Histopathology 35:82-84, 1999
29. Anonymous: Prognostic importance of occult axillary lymph node micrometastases from breast cancers. International (Ludwig) Breast Cancer Study Group. Lancet 335:1565-1568, 1990
30. Turner R, Ollila D, Stern S, et al: Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23:263-267, 1999
31. Cserni G: Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up. J Clin Pathol 52:922-924, 1999
32. Veronesi U, Zurrida S, Mazzarol G, et al: Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 25:806-808, 2001
33. Yu L, Flotte T, Tanabe K, et al: Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer 86:617-627, 1999
34. Turner RR, Giuliano AE, Hoon DS, et al: Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25:798-805, 2001
35. Tjan-Heijnen VC, Buit P, de Widt-Evert LM, et al: Micrometastases in axillary lymph nodes: An increasingn classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure. Breast Cancer Res Treat 70:81-88, 2001
36. Dowlatshahi K, Fan M, Anderson JM, et al: Occult metastases in sentinel nodes of 200 patients with operable breast cancer. Ann Surg Oncol 8:675-681, 2001
37. Kaufman MH: Observations on some of the plates used to illustrate the Lymphatics section of Andrew Fyfe's Compendium of the Anatomy of the Human Body, Published in 1800. Clinical Anatomy 12:27-34, 1999
38. Tanis P, Nieweg O, Valdes OR, et al: Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg 192:399-409, 2001
39. Uren RF, Howman-Giles RB, Thompson JF: Demonstration of second-tier lymph nodes during preoperative lymphoscintigraphy for melanoma: Incidence varies with primary tumor site. Ann Surg Oncol 5:517-521, 1998
40. Thelmo MC, Morita ET, Treseler PA, et al: Micrometastasis to in-transit lymph nodes from extremity and truncal malignant melanoma. Ann Surg Oncol 8:444-448, 2001
41. Uren R, Howman-Giles R, Thompson J, et al: Interval nodes: The forgotten sentinel nodes in patients with melanoma. Arch Surg 135:1168-1172, 2000
42. Balch CM, Lange JR: Lymphatic mapping and sentinel node lymphadenectomy for cancer: An overview. Ann Surg Oncol 8:1S-4S, 2001
43. Pendas S, Dauway E, Cox C, et al: Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am Surg 65:500-505; discussion 505-506, 1999
44. Weaver D, Krag D, Ashikaga T, et al: Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: A multicenter study. Cancer 88:1099-1107, 2000
45. Chua B, Ung O, Taylor R, et al: Treatment implications of a positive sentinel lymph node biopsy for patients with early-stage breast carcinoma. Cancer 92:1769-1774, 2001
46. Liang WC, Sickle-Santanello BJ, Nims TA: Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node? Am J Surg 182:365-368, 2001
47. Moghimi SM, Rajabi-Siahboomi R: Advanced colloid-based systems for efficient delivery of drugs and diagnostic agents to the lymphatic tissues. Prog Biophys Molec Biol 65:221-249, 1996
48. Stratmann S, McCarty T, Kuhn J: Radiation safety with breast sentinel node biopsy. Am J Surg 178:454-457, 1999
49. Fitzgibbons P, LiVolsi VA: Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy. Surgical Pathology Committee of the College of American Pathologists, and the Association of Directors of Anatomic and Surgical Pathology. Am J Surg Pathol 24:1549-1551, 2000
50. Miner T, Shriver C, Flicek P, et al: Guidelines for the safe use of radioactive materials during localization and resection of the sentinel lymph node. Ann Surg Oncol 6:75-82, 1999
51. Glass EC, Basinski JE, Krasne DL, et al: Radiation safety considerations for sentinel node techniques. Ann Surg Oncol 6:10-11, 1999
52. Zarbo RJ, Gephardt GN, Howanitz PJ; Intralaboratory timeliness of surgical pathology reports. Results of two College of American Pathologists Q-Probes studies of biopsies and complex specimens. Arch Pathol Lab Med 120:234-244, 1996
53. Turner R, Giuliano A, Hoon D, et al: Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg 25:798-805, 2001
54. Lawrence W: ADASP recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease. Virchows Arch 439:601-603, 2001
55. Kane J, Edge S, Winston J, et al: Intraoperative pathologic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection. Ann Surg Oncol 8:361-367, 2001
56. Gibbs J, Huang P, Zhang P, et al: Accuracy of pathologic techniques for the diagnosis of metastatic melanoma in sentinel lymph nodes. Ann Surg Oncol 6:699-704, 1999
57. Stojadinovic A, Allen P, Clary B, et al: Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann Surg 235:92-98, 2002
58. Tanis P, Boom R, Koops H, et al: Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 8:222-226, 2001
59. Koopal SA, Tiebosch AT, Albertus Piers D, et al: Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer 89:1720-1725, 2000
60. Messina J, Glass L, Cruse C, et al: Pathologic examination of the sentinel lymph node in malignant melanoma. Am J Surg Pathol 23:686-690, 1999
61. Rubio I, Korourian S, Cowan C, et al: Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer. Ann Surg Oncol 5:689-694, 1998
62. Cserni G: The potential value of intraoperative cytology of axillary sentinel lymph nodes in breast cancer patients. Am Surgeon 67:86-91, 2001
63. Motomura K, Inaji H, Komoike Y, et al: Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87:597-601, 2000
64. Weiser MR, Montgomery LL, Susnik B, et al: Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile? Ann Surg Oncol 7:651-655, 2000
65. Turner R, Hansen N, Stern S, et al: Intraoperative examination of the sentinel lymph node for breast carcinoma staging. Am J Clin Pathol 112:627-634, 1999
66. Morton DL: Lymphatic mapping and sentinel lymphadenectomy for melanoma: Past, present, and future. Ann Surg Oncol 8:22S-28S, 2001
67. Martin RC, Fey J, Yeung H, et al: Highest isotope count does not predict sentinel node positivity in all breast cancer patients. Annals of Surgical Oncology 8:592-597, 2001
68. Martin RC, Edwards MJ, Wong SL, et al: Practice guidelines for optimal gamma probe detection of sentinel lymph nodes in breast cancer: Results of a multi-institutional study. Surgery 128:139-144, 2000
69. Porter G, Ross M, Berman R, et al: How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma? Surgery 128:306-311, 2000
70. Turner RR, Chu KU, Qi K, et al: Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89:574-581, 2000
71. Cochran AJ, Huang RR, Guo J, et al: Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol 8:13S-17S, 2001
72. Zervos EE, Badgwell BD, Abdessalam SF, et al: Selective analysis of the sentinel node in breast cancer. Am J Surg 182:372-376, 2001
73. Farshid G, Pradhan M, Kollias J, et al: Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma. Cancer 89:2527-2537, 2000
74. Viale G, Bosari S, Mazzarol G, et al: Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer 85:2433-2438, 1999
75. Meyer J: Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen. J Surg Oncol 69:212-218, 1998
76. Torrenga H, Rahusen F, Meijer S, et al: Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 54:550-552, 2001
77. Baisden B, Askin F, Lange J, et al: HMB-45 immunohistochemical staining of sentinel lymph nodes: A specific method for enhancing detection of micrometastases in patients with melanoma. Am J Surg Pathol 24:1140-1146, 2000
78. Blaheta H, Sotlar K, Breuninger H, et al: Does intensive histopathological workup by serial sectioning increase the detection of lymph node micrometastasis in patients with primary cutaneous melanoma? Melanoma Res 11:57-63, 2001
79. Shidham V, Qi D, Acker S, et al. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: Higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45. Am J Surg Pathol 25:1039-1046, 2001.
80. van Diest PJ, Torrenga H, Meijer S, et al: Pathologic analysis of sentinel lymph nodes. Semin Surg Oncol 20:238-245, 2001
81. Jensen K, Kohler S, Rouse R: Cytokeratin staining in Merkel cell carcinoma: An immunohistochemical study of cytokeratins 5/6, 7, 17, and 20. Appl Immunohistochem Molecul Morphol 8:310-315, 2000
82. Shinzato M, Shamoto M, Hosokawa S, et al: Differentiation of Langerhans cells from interdigitating cells using CD1a and S-100 protein antibodies. Biotech Histochem 70:114-118, 1995
83. Xu X, Roberts S, Pasha T, et al: Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 124:1310-1313, 2000
84. Chiu A, Hoda S, Yao D, et al: A potential source of false-positive sentinel nodes: Immunostain misadventure. Arch Pathol Lab Med 125:1497-1499, 2001
85. Linden M, Zarbo R: Cytokeratin immunostaining patterns of benign, reactive lymph nodes: Applications for the evaluation of sentinel lymph node specimen. Appl Immunohistochem Mol Morphol 9:297-301, 2001
86. Bautista NC, Cohen S, Anders KH: Benign melanocytic nevus cells in axillary lymph nodes. A prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 102: 102-108, 1994
87. Parkash V, Vidwans M, Carter D: Benign mesothelial cells in mediastinal lymph nodes. Am J Surg Pathol 23:1264-1269, 1999
88. Pantel K, Hosch SB: Molecular profiling of micrometastatic cancer cells. Ann Surg Oncol 8:18S-21S, 2001
89. Sung J, Li W, Shivers SP, et al: Molecular analysis in evaluating the sentinel node in malignant melanoma. Ann Surg Oncol 8:29S-30S, 2001
90. Palmieri G, Ascierto P, Cossu A, et al: Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay. J Clin Oncol 19:1437-1443, 2001
91. Maruyama R, Sugio K, Fukuyama Y, et al: Evaluation of p53 alterations in occult lymph node metastases. J Surg Oncol 73:143-147, 2000
92. Yamaguchi K, Chijiiwa K, Torato N, et al: Ki-ras codon 12 point and P53 mutations: A molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer. Am J Gastroenterol 95:1939-1945, 2000
93. Hoon DS, Sarantou T, Doi F, et al: Detection of metastatic breast cancer by beta-hCG polymerase chain reaction. Int J Cancer 69:369-374, 1996
94. Schoenfeld A, Luqmani Y, Smith D, et al: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54:2986-2990, 1994
95. Bostick PJ, Morton DL, Turner RR, et al: Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. J Clin Oncol 17:3238-3244, 1999
96. Blaheta H, Paul T, Sotlar K, et al: Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: Association with Breslow's tumour thickness. Br J Dermatol 145:195-202, 2001
97. Li W, Stall A, Shivers S, et al: Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg 231:795-803, 2000
98. Wascher RA, Bostick PJ, Huynh KT, et al: Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes. Br J Cancer 85:1340-1346, 2001
99. Bilchik AJ, Saha S, Wiese D, et al: Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial. Journal of Clinical Oncology 19:1128-1136, 2001
100. Epstein JI, Erlandson RA, Rosen PP: Nodal blue nevi. A study of three cases. Am J Surg Pathol 8:907-915, 1984
101. Fraggetta F, Vasquez E: Epithelial inclusion in axillary lymph node associated with a breast carcinoma: Report of a case with a review of the literature. Pathol Res Prac 195:263-266, 1999
102. Bostick P, Chatterjee S, Chi D, et al: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16:2632-2640, 1998
103. Battyani Z, Xerri L, Hassoun J, et al: Tyrosinase gene expression in human tissues. Pigment Cell Res 6:400-405, 1993
104. Kuehn T, Kreienberg R: Sentinel node mapping in gynecological malignancies. Arch Gynecol Obstet 264:113-115, 2000
105. Bilchik AJ, Saha S, Tsioulias GJ, et al: Aberrant Drainage and Missed Micrometastases: The value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 8:82S-85S, 2001
106. Derossis AM, Fey J, Yeung H, et al: A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surgeons 193:473-478, 2001
107. Ross CM: Sentinel node dissection in early stage breast cancer: Ongoing prospective randomized trials in the USA. Ann Surg Oncol 8:77S-81S, 2001
108. Miltenburg DM, Miller C, Karamlou TB, et al: Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138-142, 1999
109. Giuliano AE: Current status of sentinel lymphadenectomy in breast cancer. Ann Surg Oncol 8:52S-55S, 2001
110. McMasters KM, Reintgen DS, Ross MI, et al: Sentinel lymph node biopsy for melanoma: Controversy despite widespread agreement. J Clin Oncol 19:2851-2855, 2001
111. Dessureault S, Soong SJ, Ross MI, et al: Improved staging of node negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol 8:766-770, 2001
112. Mehrany K, Otley CC, Weenig RH, et al: A meta-analysis of the prognostic significance of sentinel lymph node status in merkel cell carcinoma. Dermatol Surg 28:113-117, 2002
113. Lohmann CM, Coit DG, Brady MS, et al: Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors. Am J Surg Pathol 26:47-55, 2002
114. Siewert JR, Sendler A: Potential and futility of sentinel node detection for gastric cancer. Recent Results Cancer Res 157:259-269, 2000
115. Anonymous: AJCC Cancer Staging Manual. Philadelphia, PA, Lippincott Williams & Wilkins, 1997
116. Esser S, Reilly WT, Riley LB, et al: The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 44:850-854, 2001
117. Bendavid Y, Latulippe JF, Younan RJ, et al: Phase I study on sentinel lymph node mapping in colon cancer: A preliminary report. J Surg Oncol 79:81-84, 2002
118. Hiratsuka M, Miyashiro I, Ishikawa O, et al: Application of sentinel node biopsy to gastric cancer surgery. Surgery 129:335-340. 2001
119. Bilchik A, Saha S, Tsioulias G, et al: Aberrant drainage and missed micrometastases: The value of lymphatic mapping and focused analysis of sentinel lymph nodes in gastrointestinal neoplasms. Ann Surg Oncol 8:82S-85S, 2001
120. Joosten JJ, Strobbe LJ, Wauters CA, et al: Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 86:482-486, 1999
121. de Hullu JA, Hollema H, Piers DA, et al: Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva. J Clin Oncol 18:2811-2816, 2000
122. Levenback C, Coleman RL, Burke TW, et al: Intraoperative lymphatic mapping and sentinel node identification with blue dye in patients with vulvar cancer. Gynecol Oncol 83:276-281, 2001
123. Dargent D, Martin X, Mathevet P: Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer. Gynecol Oncol 79:411-415, 2000
124. O'Boyle JD, Coleman RL, Bernstein SG, et al: Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: A pilot study. Gynecol Oncol 79:238-243, 2000
125. Malur S, Krause N, Kohler C, et al: Sentinel lymph node detection in patients with cervical cancer. Gynecol Oncol 80:254-257, 2001
126. Pelizzo MR, Boschin IM, Toniato A, et al: The sentinel node procedure with Patent Blue V dye in the surgical treatment of papillary thyroid carcinoma. Acta Oto-Laryngologica 121:421-424, 2001
127. Catarci M, Zaraca F, Angeloni R, et al: Preoperative lymphoscintigraphy and sentinel lymph node biopsy in papillary thyroid cancer. A pilot study. J Surg Oncol 77:21-24, 2001 (suppl)
128. Dixon E, McKinnon JG, Pasieka JL: Feasibility of sentinel lymph node biopsy and lymphatic mapping in nodular thyroid neoplasms. World J Surg 24:1396-1401, 2000
129. Fukui Y, Yamakawa T, Taniki T, et al: Sentinel lymph node biopsy in patients with papillary thyroid carcinoma. Cancer 92:2868-2874, 2001.
130. Baloch ZW, LiVolsi VA: Post fine-needle aspiration histologic alterations of thyroid revisited. Am J Clin Pathol 112:311-316, 1999
131. Hoffman HT: Surgical treatment of cervical node metastases from squamous cell carcinoma of the upper aerodigestive tract: Evaluation of the evidence for modifications of neck dissection. Head Neck 23:907-915, 2001
132. Byers RM, Weber RS, Andrews T, et al: Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14-19, 1997
133. Shoaib T, Soutar DS, MacDonald DG, et al: The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 91:2077-2083, 2001
134. Mozzillo N, Chiesa F, Botti G, et al: Sentinel node biopsy in head and neck cancer. Ann Surg Oncol 8:103S-105S, 2001
135. Stoeckli SJ, Steinert H, Pfaltz M, et al: Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 125:221-226, 2001
136. Taylor RJ, Wahl RL, Sharma PK, et al: Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 127:970-974, 2001
137. Liptay MJ, Grondin SC, Fry WA, et al: Intraoperative sentinel lymph node mapping in non-small-cell lung cancer improves detection of micrometastases. J Clin Oncol 20:1984-1988, 2002